Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001221590-26-000002

Director bought 2,000 shares at $11.21 ($22,420)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BIENAIME JEAN JACQUES Director 2026-03-09 Purchase 10b5-1 +2,000 $11.21 $22,420 7,450 D
Open-market purchases · 2,000 sh · avg $11.21 · $22,420
Loading xslF345X05/form4-03112026_080355.xml…